(Q33322318)

25 July 2017

title

Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

5 December 2022

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

sex organ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

genitourinary system

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

reproduction

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

male contraceptive agent

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

pituitary gonadotropins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

Southeast Asia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

5 December 2022

author name string

W. Pangkahila

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831798

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1831798

5 December 2022

publication date

1 August 1991

1 reference

full work available at URL

25 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2605.1991.tb01089.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2605.1991.tb01089.x/fullpdf

5 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

International Journal of Andrology

5 December 2022

published in

1 reference

25 July 2017

volume

14

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

248-256

1 reference

Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

Plasma levels and pharmacokinetics of ethynyl estrogens in various populations: II. Mestranol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

Elevated serum lipids in hypogonadal men with and without hyperprolactinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

Contraceptive efficacy of testosterone-induced azoospermia in normal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.1991.TB01089.X

Ovarian function following a single administration of depomedroxyprogesterone acetate (DMPA) at different doses

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Sperm suppression with monthly injections of medroxyprogesterone acetate combined with testosterone enanthate at a high dose (500 mg)

5 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. II. High initial dose

5 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Testicular function in potential sperm donors: normal ranges and the effects of smoking and varicocele

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.

5 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Androgens directly stimulate proliferation of bone cells in vitro

5 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception

5 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Return of ovulation following a single injection of depo-medroxyprogesterone acetate: A pharmacokinetic and pharmacodynamic study

5 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate of testosterone cypionate

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men

5 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men

5 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man

5 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. World Health Organization Task Force on Long-acting Systemic Agents for Fertility Regulation

5 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2605.1991.TB01089.X

5 December 2022

Identifiers

1 reference

25 July 2017

1 reference